Skip to main content
. 2018 Jun 23;9(15):2702–2712. doi: 10.7150/jca.25646

Table 4.

Comparison of clinicopathological findings in each subgroup

Total Subgroup 1 (%) Subgroup 2 (%) Subgroup 3 (%) Subgroup 4 (%) p value
Total 109 15 (13.8) 15 (13.8) 32 (43.0) 47 (43.1)
Sex Men : Women 57 : 52 13 : 2 8 : 7 15 : 17 21 : 26 N. S.
Age (year) Range (median) 40-93 (67.0) 55-85 (71.5) 46-79 (70.4) 44-79 (64.5) 40-78 (67.9) N. S.
Site Right 40 (36.7) 7 (46.7) 10 (66.7) 12 (37.5) 11 (23.4) < 0.05
Left 69 (63.3) 8 (53.3) 5 (33.3)** 20 (62.5) 36 (76.6)**
Macroscopic type 0-I type 37 (33.9) 8 (53.3) 6 (40.0) 11 (34.3) 12 (29.8) N. S.
0-IIa type 24 (22.0) 1 (6.7) 2 (13.3) 11 (34.3) 10 (21.3)
0-IIc type 16 (14.7) 4 (26.7) 2 (13.3) 3 (9.4) 7 (14.9)
0-IIa+IIc type 28 (25.7) 1 (6.7) 4 (26.6) 5 (15.7) 17 (36.2)
LST type 5 (4.6) 1 (6.7) 1 (6.7) 2 (6.3) 1 (2.1)
Histological type WDA 36 (33.0) 9 (60.0) 7 (46.7) 11 (34.3) 9 (19.1) < 0.01
MDA 69 (63.3) 5 (33.3)* 7 (46.7) 19 (59.4) 38 (80.9)*
PAP 2 (1.8) 0 1 (6.7) 1 (3.1) 0
POR 2 (1.8) 1 (6.7) 0 1 (3.1) 0
pSM depth pSM1 8 (7.3) 1 (6.7) 1 (6.7) 4 (12.5) 2 (4.3) N. S.
pSM2 101 (92.7) 14 (93.3) 14 (93.3) 28 (87.5) 45 (95.7)
Lymphatic invasion Low 104 (95.4) 14 (93.3) 15 29 (90.6) 46 N. S.
High 5 (4.6) 1 (6.7) 0 3 (9.4) 1
Venous invasion Low 102 (93.6) 14 (93.3) 15 28 (87.5) 45 (95.7) N. S.
High 7 (6.4) 1 (6.7) 0 4 (12.5) 2 (4.3)
pN pN0 80 (73.4) 12 (80.0) 6 (40.0) 24 (75.0) 38 (80.9) < 0.05
pN1 29 (26.6) 3 (20.0) 9 (60.0)*, ** 8 (25.0)* 9 (19.1)**
Tumor budding Low 99 (90.8) 14 (93.3) 13 (86.7) 29 (90.6) 43 (91.5) N. S.
High 10 (9.2) 1 (6.7) 2 (13.3) 3 (9.4) 4 (8.5)

*: p < 0.05, **: p < 0.01

Macroscopic type: I, protruded type; IIa, flat elevated type; IIc, flat depressed type; LST, laterally spreading tumor; WDA, well-differentiated adenocarcinoma; MDA, moderately differentiated adenocarcinoma; PAP, papillary adenocarcinoma; POR, poorly differentiated adenocarcinoma.